產(chǎn)品詳情
簡單介紹：
Anti-C17orf42抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-C17orf42抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C17orf42
Cat. Number:
Anti-C17orf42抗體KL-9639R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
C17orf42 is a 360 amino acid protein that exists as two alternatively spliced isoforms and is encoded by a gene mapping to human chromosome 17. Chromosome 17 makes up over 2.5% of the human genome Anti-C17orf42抗體with about 81 million bases encoding over 1,200 genes. Two key tumor suppressor genes are associated with chromosome 17, namely, p53 and BRCA1. Tumor suppressor p53 is necessary for maintenance of cellular genetic integrity by moderating cell fate through DNA repair versus cell death. Malfunction or loss of p53 expression is associated with malignant cell growth and Li-Fraumeni syndrome. Like p53, BRCA1 is directly involved in DNA repair, specifically it is recognized as a genetic determinant of early onset breast cancer and predisposition to cancers of the ovary, colon, prostate gland and fallopian tubes. Chromosome 17 is also linked to neurofibromatosis, a condition characterized by neural and epidermal lesions, and dysregulated Schwann cell growth. Alexander disease, Birt-Hogg-Dube syndrome and Canavan disease are also associated with chromosome 17.
Also known as:
Chromosome 17 openAnti-C17orf42抗體 reading frame 42; FLJ22729; Hypothetical protein LOC79736; MGC24674; UPF0629 protein C17orf42; TEFM_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C17orf42.
●
Predicted Molecular Weight: 38kDa.
Storage:
Shipped at 4℃, Store Anti-C17orf42抗體at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-C17orf42抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-C17orf42抗體dilutions must be determined by the end user.
kl049Ra01 三葉因子1(TFF1)多克隆抗體 Polyclonal Antibody to Trefoil Factor 1 (TFF1)
kl050Mu02 雌**受體α(ERα)多克隆抗體 Polyclonal Antibody to Estrogen Receptor Alpha (ERa)
kl053Mu02 細(xì)胞色素P450家族成員7A1(CYP7A1)多克隆抗體 Polyclonal Antibody to Cytochrome P450 7A1 (CYP7A1)
kl054Mu02 凋亡蛋白酶激活因子1(Akl1)多克隆抗體 Polyclonal Antibody to Apoptotic Peptidase Activating Factor 1 (Akl1)
kl054Ra01 凋亡蛋白酶激活因子1(Akl1)多克隆抗體 Polyclonal Antibody to Apoptotic Peptidase Activating Factor 1 (Akl1)
kl067Mu02 YY肽(PYY)多克隆抗體 Polyclonal Antibody to Peptide YY (PYY)
kl068Ra01 多藥耐藥關(guān)聯(lián)蛋白1(MRP1)多克隆抗體 Polyclonal Antibody to Multidrug Resistance Associated Protein 1 (MRP1)
kl070Eq01 類胰蛋白酶(TPS)多克隆抗體 Polyclonal Antibody to Tryptase (TPS)
kl070Mu02 類胰蛋白酶(TPS)多克隆抗體 Polyclonal Antibody to Tryptase (TPS)
kl075Mu02 促胰液素(SCT)多克隆抗體 Polyclonal Antibody to Secretin (SCT)
kl077Mu02 ⅡD組磷脂酶A2(PLA2G2D)多克隆抗體 Polyclonal Antibody to Phospholikle A2, Group IID (PLA2G2D)
kl081Mu02 70kDa熱休克蛋白1A(HSPA1A)多克隆抗體 Polyclonal Antibody to Heat Shock 70kDa Protein 1A (HSPA1A)
kl091Mu02 肝腎骨堿性磷酸酶(ALPL)多克隆抗體 Polyclonal Antibody to Alkaline Phosphatase, Liver/Bone/Kidney (ALPL)
kl092Mu01 骨涎蛋白(BSP)多克隆抗體 Polyclonal Antibody to Bone Sialoprotein (BSP)
kl092Mu02 骨涎蛋白(BSP)多克隆抗體 Polyclonal Antibody to Bone Sialoprotein (BSP)
kl093Mu01 腦指蛋白(BFP)多克隆抗體 Polyclonal Antibody to Brain Finger Protein (BFP)
kl093Mu02 腦指蛋白(BFP)多克隆抗體 Polyclonal Antibody to Brain Finger Protein (BFP)
